<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>A1C on GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</title><link>https://glp1decode.com/zh/tags/a1c/</link><description>Recent content in A1C on GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</description><image><title>GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</title><url>https://glp1decode.com/images/default-og.png</url><link>https://glp1decode.com/images/default-og.png</link></image><generator>Hugo</generator><language>zh</language><lastBuildDate>Fri, 19 Jun 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://glp1decode.com/zh/tags/a1c/index.xml" rel="self" type="application/rss+xml"/><item><title>Ozempic治疗2型糖尿病：血糖控制与更多</title><link>https://glp1decode.com/zh/posts/ozempic-diabetes-blood-sugar-2026/</link><pubDate>Fri, 19 Jun 2026 00:00:00 +0000</pubDate><guid>https://glp1decode.com/zh/posts/ozempic-diabetes-blood-sugar-2026/</guid><description>Ozempic最初是为治疗2型糖尿病而开发的，而非减重。以下是它在控制血糖方面的效果、可期待的血红蛋白A1C降幅，以及与其他糖尿病药物的比较。</description></item></channel></rss>